Global X Genomics & Biotechnology ETF (GNOM US) stock market data APIs
69.4494
-1.45(-2.1%)
as of September 22, 2026
Try our APIs with
free plan!
Global X Genomics & Biotechnology ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
69.4494
Open
68.0014
High
70.0421
Low
66.8755
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Global X Genomics & Biotechnology ETF data using free add-ons & libraries
End-of-day & Earnings data
Get Global X Genomics & Biotechnology ETF Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Global X Genomics & Biotechnology ETF End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Global X Genomics & Biotechnology ETF News
New
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height...
ETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins?
Quick Read ARKG's concentrated, active bet on pre-revenue biotech gained 32% YTD but lost 13 more percentage points than GNOM over the past five years. ARKG's $1.4 billion in assets versus GNOM's $75...
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?
The biotech industry has held up well this year despite macroeconomic uncertainty, pricing pressures and regulatory challenges. Strong first-quarter earnings, new drug approvals and encouraging clinic...
We now live in a world of rolling bubbles – analyst
[Bubble] Petrovich9 The top 10 stocks in the U.S. now represent approximately 45% of total market capitalization, a level of concentration that has broken traditional market trend lines and left inve...
Get Global X Genomics & Biotechnology ETF fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
